Skip to content
Contact Us
Onc_cell divide_AdobeStock_293439993 Onc_cell divide_AdobeStock_293439993

Next-Gen Oncology CRO Services

Oncology drug development is evolving rapidly. Precision keeps pace.
Tomorrow's targeted therapies require a shift away from yesterday's processes. Precision's specialized oncology CRO has integrated and aligned capabilities to efficiently navigate and execute complex clinical trials. Expedite your targeted oncology therapy with a CRO rooted in developing novel therapies and delivering commercial success.

Oncology CRO services spanning discovery, development and commercialization

Deliver your oncology therapy at scale with a CRO built to streamline development for personalized medicines. World-class teams and technologies, broad capabilities, and deep oncology expertise will support you from promising molecule to patient impact.

  • Explore
    clinical-trial-services

    Global CRO Solutions

    Global trials for oncology, rare diseases and other complex diseases face unique challenges. Precision partners with you to meet them head-on through our extensive footprint across the globe.
    Explore
  • Explore
    specialty-lab-services

    Central & Specialty Lab Services

    Precision for Medicine was built specifically to support biomarker-driven development programs, with a strong focus on biomarker assay development.
    Explore
  • Explore
    cells-icon

    Manufacturing Solutions

    Advancing Manufacturing for Next-Generation Medicines
    Explore
  • Explore
    biospecimens

    Biospecimen Collections

    The most comprehensive resource of biospecimens and biomarker services for your diagnostic and therapeutic R&D
    Explore
  • Explore
    companion-diagnostic

    Companion Diagnostics

    The route to companion diagnostic commercialization is complex and must be well-planned to ensure that the test and drug come to market together and with the best possible patient access.
    Explore
  • Explore
    Virtual-Sample-Management

    Virtual Sample Management

    Lost samples are more than lost data—they are missed opportunities for insight and can cause costly delays. Discover our solution now
    Explore

Oncology CRO services delivered by exceptionally dedicated clinical teams

Precision for Medicine - Experience by clinical phase and cancer type Clinical Phase Cancer Type Active Project Dashboard

Recent Oncology articles

Visit blog
basket and umbrella trials

Experts in basket & umbrella trials for oncology early phase development

As an oncology contract research organization, we excel at running complex trials such as basket and umbrella trials with adaptive design, master protocols with multiple treatment cohorts, and biomarker-driven trials with intricate sample collection. Our team of clinical trial design experts is ready to assist on your next trial.

Clinical Trial Design Services
Markentive-29 1

Driving Innovation in Cell & Gene Therapy from Development to Commercialization

With pioneering experience and integrated services, we support the entire lifecycle of cell and gene therapies. Partner with the leader in clinical development, manufacturing, and commercialization to bring your groundbreaking treatments to market.

Explore Precision CGTx Expertise

Biomarker assay development and validation through to companion diagnostics

Percentage of oncology trials graph

Biomarker use in Oncology clinical trials for the industry is now over 55% of all studies. Biomarker validation is critical to your drug and clinical program’s success. Delivering new biomarker tests to support clinical trials and personalized therapy is our passion. Work with the leaders in biomarker development and validation at Precision for Medicine.

Oncology expertise in Biomarker Development including:

  • Liquid biopsy-based biomarkers: ctDNA or CTC
  • Solid tumor biomarkers: IHC, multiplex immunofluorescence
  • Immune monitoring biomarkers: Flow cytometry, epigenetic cell phenotyping

Developing a companion diagnostic for your clinical program? Precision for Medicine has over 15 years of experience as an oncology CRO in guiding sponsors down the companion diagnostic pathway.

Precision Companion Diagnostics

  • Biomarker
    assays services for any tissue type

    We leverage established technologies, proprietary approaches, and develop and validate biomarker assays to generate robust biomarker data in samples ranging from nucleic acids to tissues

    Biomarkers & Specialty Lab Services
  • tissue-cross-reactivity_header

    Tissue

    • Multiplex IHC with centralized pathology reading
    • Quantitative IF—up to 9 concurrent markers
    • FISH, ISH, sequencing
    • GLP tissue cross-reactivity (TCR)
  • iStock-1279507600 (3) (1)

    Cell

    • Flow cytometry—standard and spectral flow up to 64 color panels

    • Functional assays—eg, ELISpot/FluoroSpot, T-cell activation, ADCC

    • Single-cell quantitative image analysis

    • Proprietary cell separation technology for CTCs

  • AdobeStock_208547466

    Protein

    • Comprehensive large-molecule bioanalysis—PK, ADA, NAb, TAb

    • Multiplex cytokine profiling, receptor occupancy, tetramer staining

    • Custom ligand binding assays—ELISA, MSD, Olink®

    • Quantitative image analysis of protein expression (eg, phosphorylation, signaling)

    • Automated Western blotting—Jess™

  • iStock-1428646288

    RNA

    • Gene expression profiling—NanoString

    • Bulk and single-cell RNASeq

    • RT-PCR and RT-ddPCR

    • Spatial transcriptomics

  • 22.-Gene-mutation,-damage-to-a-part-of-a-cells-DNA

    DNA

    • PCR—ddPCR, qPCR

    • Immunophenotyping via proprietary epigenetic platform

    • Sequencing—whole genome, whole exome, targeted sequencing

    • cfDNA analysis

Proprietary technologies empowering Precision’s oncology CRO services

Part of what makes Precision unique is our history of scientific innovation as an oncology CRO. Not only do we combine state-of-the-art approaches to maximize the information each tumor provides, we create proprietary technologies that solve oncology and immuno-oncology clinical research study challenges.
  • Advance Immune Cell Phenotyping
  • Investigate Circulating Tumor Cells (CTCs)
  • Revolutionize Biomarker Operations

  • Epiontis ID®

    Precision’s patented Epiontis® ID technology is a robust, flexible, and cost-effective platform for immune cell phenotyping based on epigenetic cell counting. With minimal sample processing requirements that simplifies global trial logistics and robust, reproducible results that can be compared between sites and studies, Epiontis ID is an ideal solution for immune monitoring in both early-stage and late-stage clinical trials.
    Explore
    17c6daf230914588bc3d28a14f5beeaf

  • ApoStream®

    ApoStream® is an antibody-free method for capturing and enriching circulating tumor cells as well as other rare cell types from liquid biopsies. When isolated from blood, CTCs are a more accessible source of information about the primary cancer than a surgical biopsy.
    Explore
    17c6daf230914588bc3d28a14f5beeaf

  • virtual Sample Inventory Management (vSIM)

    Oncology trials today are collecting more and more biological data samples from patients. QuartzBio’s solution for virtual Sample Inventory Management centralizes and harmonizes sample data and metadata from all central labs, specialty labs, biorepositories, and EDC.
    Explore
    17c6daf230914588bc3d28a14f5beeaf

Companion diagnostics development & consulting oncology CRO services

Are you planning a companion diagnostic? Precision’s Companion Diagnostics team can guide
and support your development, regulatory, and commercialization journey. The route to market for a companion
diagnostic is complex and must be well planned to ensure that the test and drug come to market together,
with the best possible patient access.

Precision for Medicine CDx Diagram Learn more – Companion Diagnostics
hey-numbers

Precision Site Network (PSN)

Relationships with the oncology investigator community matter, as selecting the right sites can predetermine many factors, from on-time enrollment to high-quality data.

Precision invests heavily in building these relationships to make the right sites available to our partners' studies. 

Explore the PSN >

80

Global Oncology Centers

Access preidentified and prequalified centers from around the world with extensive infrastructures, expertise, and most importantly, access to the patient populations you need for your trials.

people
Every data point and every patient matters

Precision Centralized Monitoring

Ensure consistent site adherence and data-driven decision-making throughout your trial. Precision Centralized Monitoring bridges the gaps in standard data review processes with integrated oncology research standards, such as RECIST, RECIST 1.1, and CTCAE.

The team’s extensive oncology expertise guarantees a comprehensive examination of data against specific standards, maintaining the integrity of your dataset.

Leverage tools like JReview Cloud, SAS, and Precision’s Smart Patient Profiles to enhance data visualizations, making remote reviews more efficient and insightful.

Dive Deeper

Curated Insights

Experiences, tips, and perspectives from experts on the front lines of research. 

 All Resources

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore